4.6 Article

Sanyin Formula Enhances the Therapeutic Efficacy of Paclitaxel in Triple-Negative Breast Cancer Metastases through the JAK/STAT3 Pathway in Mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy

Arokia Vijaya Anand Mariadoss et al.

Summary: The study fabricated p-Coumaric acid-loaded aptamer conjugated starch nanoparticles and demonstrated high cytotoxicity in triple-negative breast cancer MDAMB-231 cells. These nanoparticles efficiently inhibited MDA-MB-231 cells by regulating apoptosis.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Article Oncology

Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT

Yihui Zhu et al.

Summary: Exosomes enriched with MMP-1 can promote distant metastasis of triple-negative breast cancer cells and enhance their invasion and migration capabilities. This study suggests that MMP-1 may serve as a potential molecular marker.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Article Plant Sciences

Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway

Hailong Li et al.

Summary: Amorphophalli Rhizoma (APR) has significant inhibitory effects on estrogen receptor-positive (ER+) and human epidermal growth factor receptor-positive (HER2+) breast cancer cells by inhibiting the PI3K/AKT signaling pathway, affecting cell growth, proliferation, migration, and invasion.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Review Oncology

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

Sara G. Manore et al.

Summary: Breast cancer, the most commonly diagnosed cancer in women, often metastasizes due to the IL-6-mediated signaling pathway. Abnormal activation of this pathway promotes breast cancer metastasis while suppressing the anti-tumor immune response. Components of the IL-6 pathway are potential targets for cancer therapeutics.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Remodeling the ECM: Implications for Metastasis and Tumor Dormancy

Julie S. Di Martino et al.

Summary: While most primary tumors can be effectively treated, the challenge lies in eliminating metastases efficiently. Recent studies have shown that ECM plays a crucial role in cancer progression, regulating tumor cell metastasis and dormancy. Understanding the individual components of ECM and how they mediate tumor cell dormancy may lead to the development of new therapies targeting dormant cells and preventing metastasis outgrowth.

CANCERS (2021)

Article Biology

CD45 Immunohistochemistry in Mouse Kidney

Shirong Zheng et al.

Summary: In this study, a reliable immunohistochemistry (IHC) protocol for CD45 staining in paraffin-embedded mouse kidney sections was shared. The protocol demonstrated its utility in pathology research by significantly increasing the number of CD45-positive cells in the kidneys, indicating the ability of the CD45 antibody to recognize bone marrow cells and macrophages.

BIO-PROTOCOL (2021)

Article Oncology

Icariin induces apoptosis in breast cancer MCF-7 cells by regulating the MELK mediated PI3K/AKT signaling pathway

Danping Qian et al.

Summary: The study revealed that icariin promotes apoptosis of breast cancer cells by regulating the PI3K/AKT signaling pathway mediated by MELK. Icariin inhibits cell proliferation, induces G2/M arrest, and reduces migration ability of breast cancer cells. Overall, icariin shows therapeutic potential for breast cancer by inhibiting MELK expression and PI3K/AKT pathway.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Notch3 promotes prostate cancer-induced bone lesion development via MMP-3

Sourik S. Ganguly et al.

ONCOGENE (2020)

Article Endocrinology & Metabolism

Sodium Danshensu Inhibits Oral Cancer Cell Migration and Invasion by Modulating p38 Signaling Pathway

V. Bharath Kumar et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Oncology

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

Jiang-Jiang Qin et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Medicine, Research & Experimental

MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway

Lin Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Medicine, Research & Experimental

The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer

Xueni Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Oncology

Targeted Therapies for Triple-Negative Breast Cancer

Tomas G. Lyons

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)

Article Pharmacology & Pharmacy

Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells

Varun Sasidharan Nair et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2018)

Article Pharmacology & Pharmacy

Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer

Yue Chen et al.

JOURNAL OF DRUG TARGETING (2018)

Editorial Material Oncology

Triple-negative breast cancers - a panoply of cancer types

Fresia Pareja et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Instruments & Instrumentation

Metastatic and triple-negative breast cancer: challenges and treatment options

Sumayah Al-Mahmood et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)

Article Pharmacology & Pharmacy

Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro

Zhang-Feng Zhong et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Pharmacology & Pharmacy

Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro

Zhangfeng Zhong et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Chemistry, Medicinal

Anticancer Activity of Protocatechualdehyde in Human Breast Cancer Cells

Jieun Choi et al.

JOURNAL OF MEDICINAL FOOD (2014)

Article Pharmacology & Pharmacy

Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

Patrick J. Medina et al.

CLINICAL THERAPEUTICS (2008)

Review Oncology

Small molecule inhibitors of Stat3 signaling pathway

Jinxia Deng et al.

CURRENT CANCER DRUG TARGETS (2007)